Optimal Bayesian predictive probability for delayed response in single-arm clinical trials with binary efficacy outcome

Takuya Yoshimoto, Satoru Shinoda, Kouji Yamamoto +1

In oncology, phase II or multiple expansion cohort trials are crucial for clinical development plans. This is because they aid in identifying potent agents with sufficient activity…